November 18 · 12:00 PM ET (6:00 PM CET)
60 min · Live webinar + Q&A
AI in Clinical Trials: Advancing Trial Design and Regulatory Readiness
Industry leaders discuss how they leverage AI to optimize clinical trial design and anticipate evolving regulatory requirements, increasing the likelihood of successful drug approval.
Add to calendar
Save your seat
Free to attend. We’ll send the joining link to your email.
About the webinar
Clinical trial design and regulatory compliance are two high-impact areas where AI can help reduce drug development failures, shorten timelines, and improve the probability of successful drug approval.
One of the biggest challenges in pharmaceutical development is not simply meeting regulatory requirements, it is keeping up with changing requirements while a drug is already being developed.
The key opportunity using AI is therefore to move from reactive regulatory compliance to proactive regulatory intelligence and from static trial design to adaptive, data-driven clinical development.
The two shifts this session is about
Reactive regulatory compliance
→
Proactive regulatory intelligence
Static trial design
→
Adaptive, data-driven clinical development
Featured speakers
About Biorce
Save your seat
Biorce is a healthtech company building the first AI-native infrastructure for the entire clinical trial lifecycle. Our mission is to dramatically reduce the time and cost of clinical trial development, making innovative medicines more affordable and accessible to patients. At the core of Biorce’s innovation is Aika, the first AI-native and domain-specific operating system for clinical trials, delivering intelligence from IND to market approval.
Join us live on November 18.
Save your seat
